Zerbaxa and Respiratory acidosis - a phase IV clinical study of FDA data

Summary:

Respiratory acidosis is reported as a side effect among people who take Zerbaxa (ceftolozane sulfate; tazobactam sodium), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Humalog, and have Pneumonia pseudomonal.

The phase IV clinical study analyzes which people have Respiratory acidosis when taking Zerbaxa. It is created by eHealthMe based on reports of 1,018 people who have side effects when taking Zerbaxa from the FDA, and is updated regularly.

What is Zerbaxa?

Zerbaxa has active ingredients of ceftolozane sulfate; tazobactam sodium. eHealthMe is studying from 1,018 Zerbaxa users. Check the latest studies of Zerbaxa.

What is Respiratory acidosis?

Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease) is found to be associated with 2,242 drugs and 3,540 conditions by eHealthMe. Check the latest studies of Respiratory acidosis.

On Jul, 18, 2026

1,018 people reported to have side effects when taking Zerbaxa.
Among them, 29 people (2.85%) have Respiratory acidosis.

Could Zerbaxa cause Respiratory acidosis?

Among these 29 people:

How long have people been on Zerbaxa when they have Respiratory acidosis? *

What is the gender of people who have Respiratory acidosis when taking Zerbaxa? *

female: 17.86 %
male: 82.14 %

What is the age of people who have Respiratory acidosis when taking Zerbaxa? *

What are other drugs people take besides Zerbaxa? *

What are other side effects people have besides Respiratory acidosis? *

Sepsis (a severe blood infection that can lead to organ failure and death): 11 people, 37.93%
Pneumonia Pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa): 10 people, 34.48%
Transplant Rejection (a transplant material is not worked): 10 people, 34.48%
Cytomegalovirus Test Positive: 10 people, 34.48%
Septic Shock (shock due to blood infection): 10 people, 34.48%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 10 people, 34.48%
Pneumonia: 10 people, 34.48%
Pneumonia Necrotising (necrotizing pneumonia is a life-threatening condition in which a person breathes material into his or her lungs): 10 people, 34.48%
Hypokalemia (low potassium): 9 people, 31.03%
Anaemia (lack of blood): 9 people, 31.03%

What are the existing conditions these people have? *

Pneumonia Pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa): 10 people, 34.48%
High Blood Pressure: 9 people, 31.03%
Wheezing (a high-pitched whistling sound made while you breath): 8 people, 27.59%
Pain: 8 people, 27.59%
Asthma: 8 people, 27.59%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 8 people, 27.59%
Blood Glucose Decreased: 8 people, 27.59%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 8 people, 27.59%
Cough: 8 people, 27.59%
Cystic Fibrosis (disease of the secretary glands): 8 people, 27.59%

* Approximation only. Some reports may have incomplete information.

Do you take Zerbaxa and have Respiratory acidosis?

- Check whether Respiratory acidosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zerbaxa:

Zerbaxa (1,018 reports)

Respiratory acidosis treatments and more:

Respiratory acidosis (90,650 reports)

How severe was Respiratory acidosis and when was it recovered:

Respiratory acidosis in Zerbaxa

Expand to all the drugs that have ingredients of ceftolozane sulfate; tazobactam sodium:

Respiratory acidosis and drugs with ingredients of ceftolozane sulfate; tazobactam sodium

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zerbaxa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory acidosis:

Respiratory acidosis (2,242 drugs)

Browse all the conditions that are associated with Respiratory acidosis:

Respiratory acidosis (3,540 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ceftolozane sulfate; tazobactam sodium (the active ingredients of Zerbaxa) and Zerbaxa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.